Baby Martin-McNulty Selected Research

4- (((4- (1- carboxy- 1- methylethoxy)- 7- methylquinolin- 2- yl)carbonyl)amino)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acid

5/2007

A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baby Martin-McNulty Research Topics

Disease

7	Atherosclerosis 08/2006 - 05/2002
4	Inflammation (Inflammations) 08/2006 - 10/2002
3	Vascular Remodeling 07/2007 - 04/2005
3	Hemorrhage 05/2007 - 10/2002
3	Thrombosis (Thrombus) 05/2007 - 01/2003
3	Abdominal Aortic Aneurysm 05/2005 - 03/2003
3	Aneurysm (Aneurysms) 09/2003 - 10/2002
2	Hyperplasia 07/2007 - 03/2006
2	Hypercholesterolemia 03/2006 - 05/2002
1	Neoplasms (Cancer) 11/2019
1	Hypoxia (Hypoxemia) 06/2009
1	Infarction (Infarctions) 06/2009
1	Ischemia 06/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2009
1	Vascular Diseases (Vascular Disease) 07/2007
1	Neointima 02/2007
1	Disseminated Intravascular Coagulation 09/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2006
1	Cardiomegaly (Heart Hypertrophy) 04/2005
1	Hypertrophy 04/2005
1	Ventricular Dysfunction 04/2005
1	Fibrosis (Cirrhosis) 04/2005
1	Sclerosis 01/2005
1	Hypertension (High Blood Pressure) 12/2002
1	Atrophy 10/2002
1	Hyperlipidemias (Hyperlipidemia) 05/2002

Drug/Important Bio-Agent (IBA)

9	Angiotensin IIIBA 07/2007 - 10/2002
7	ApolipoproteinsIBA 05/2005 - 05/2002
5	Apolipoproteins E (ApoE)IBA 07/2006 - 05/2002
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2007 - 03/2003
2	rho-Associated KinasesIBA 05/2005 - 04/2005
2	fasudil (AT 877)IBA 05/2005 - 04/2005
2	CholesterolIBA 01/2005 - 05/2002
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Small Cytoplasmic RNAIBA 11/2019
1	triphenyltetrazoliumIBA 06/2009
1	Glial Fibrillary Acidic ProteinIBA 06/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2007
1	Chemokine CCL3IBA 07/2007
1	Purinergic P2Y Receptor AntagonistsIBA 05/2007
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2007
1	4- (((4- (1- carboxy- 1- methylethoxy)- 7- methylquinolin- 2- yl)carbonyl)amino)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acidIBA 05/2007
1	Clopidogrel (Plavix)FDA Link 05/2007
1	Adenosine Diphosphate (ADP)IBA 05/2007
1	4- ((4- (1- (ethoxycarbonyl)- 1- methylethoxy)- 7- methyl- 2- quinolyl)carbamoyl)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acidIBA 05/2007
1	Thromboplastin (Tissue Factor)IBA 09/2006
1	Indicators and Reagents (Reagents)IBA 09/2006
1	Dacarbazine (DIC)FDA LinkGeneric 09/2006
1	Dobutamine FDA LinkGeneric 07/2006
1	HDL CholesterolIBA 03/2006
1	GTP Phosphohydrolases (GTPases)IBA 04/2005
1	Atrial Natriuretic Factor (ANF)IBA 04/2005
1	Collagen Type III (Type III Collagen)IBA 04/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2005
1	ElastinIBA 01/2005
1	Drinking WaterIBA 01/2005
1	Enalapril FDA LinkGeneric 01/2005
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2003
1	Peptides (Polypeptides)IBA 09/2003
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2003
1	Plasminogen InactivatorsIBA 01/2003
1	Plasminogen Activator Inhibitor 1IBA 01/2003
1	LipopolysaccharidesIBA 01/2003
1	ferrous chlorideIBA 01/2003
1	FibrinIBA 01/2003
1	BatroxobinIBA 01/2003
1	PPAR alphaIBA 10/2002
1	NF-kappa B (NF-kB)IBA 10/2002
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2002
1	Estrogens (Estrogen)FDA Link 10/2002
1	Simvastatin (Zocor)FDA LinkGeneric 05/2002
1	LDL Receptors (LDL Receptor)IBA 05/2002

Therapy/Procedure

4	Ligation 06/2009 - 03/2006
1	Oral Administration 05/2007
1	Intravenous Injections 09/2006
1	Subcutaneous Infusions 01/2005